Imidazole clubbed 1,3,4-oxadiazole derivatives as potential antifungal agents. 2015

Mohmmad Younus Wani, and Aijaz Ahmad, and Rayees Ahmad Shiekh, and Khalaf J Al-Ghamdi, and Abilio J F N Sobral
Departmento de Quimica, FCTUC, Universidade de Coimbra, Rua Larga, Coimbra 3004-535, Portugal. Electronic address: waniyouns@gmail.com.

A series of compounds in which 2-(4-ethyl-2-pyridyl)-1H-imidazole was clubbed with substituted 1,3,4-oxadiazole was synthesized and subjected to antifungal activity evaluation. In vitro assays indicated that several clubbed derivatives had excellent antifungal activity against different strains of laboratory and clinically isolated Candida species. Structural Activity Relationship (SAR) studies revealed that the presence and position of substituents on the phenyl ring of the 1,3,4-oxadiazole unit, guides the antifungal potential of the compounds, where compound 4b, 4c and 4g were found to be active against all the tested fungal strains. Impairment of ergosterol biosynthesis upon the concomitant treatment of 4b, 4c and 4g, revealed the possible mechanisms of antifungal action of these compounds. Inhibitors snugly fitting the active site of the target enzyme, as revealed by molecular docking studies, may well explain their excellent inhibitory activity.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D010069 Oxadiazoles Compounds containing five-membered heteroaromatic rings containing two carbons, two nitrogens, and one oxygen atom which exist in various regioisomeric forms. Oxadiazole
D002175 Candida A genus of yeast-like mitosporic Saccharomycetales fungi characterized by producing yeast cells, mycelia, pseudomycelia, and blastophores. It is commonly part of the normal flora of the skin, mouth, intestinal tract, and vagina, but can cause a variety of infections, including CANDIDIASIS; ONYCHOMYCOSIS; VULVOVAGINAL CANDIDIASIS; and CANDIDIASIS, ORAL (THRUSH). Candida guilliermondii var. nitratophila,Candida utilis,Cyberlindnera jadinii,Hansenula jadinii,Lindnera jadinii,Monilia,Pichia jadinii,Saccharomyces jadinii,Torula utilis,Torulopsis utilis,Monilias
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D013261 Sterols Steroids with a hydroxyl group at C-3 and most of the skeleton of cholestane. Additional carbon atoms may be present in the side chain. (IUPAC Steroid Nomenclature, 1987) Sterol
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D062105 Molecular Docking Simulation A computer simulation technique that is used to model the interaction between two molecules. Typically the docking simulation measures the interactions of a small molecule or ligand with a part of a larger molecule such as a protein. Molecular Docking,Molecular Docking Simulations,Molecular Docking Analysis,Analysis, Molecular Docking,Docking Analysis, Molecular,Docking Simulation, Molecular,Docking, Molecular,Molecular Docking Analyses,Molecular Dockings,Simulation, Molecular Docking

Related Publications

Mohmmad Younus Wani, and Aijaz Ahmad, and Rayees Ahmad Shiekh, and Khalaf J Al-Ghamdi, and Abilio J F N Sobral
October 2013, Mini reviews in medicinal chemistry,
Mohmmad Younus Wani, and Aijaz Ahmad, and Rayees Ahmad Shiekh, and Khalaf J Al-Ghamdi, and Abilio J F N Sobral
December 2022, Chemical biology & drug design,
Mohmmad Younus Wani, and Aijaz Ahmad, and Rayees Ahmad Shiekh, and Khalaf J Al-Ghamdi, and Abilio J F N Sobral
January 2010, Acta poloniae pharmaceutica,
Mohmmad Younus Wani, and Aijaz Ahmad, and Rayees Ahmad Shiekh, and Khalaf J Al-Ghamdi, and Abilio J F N Sobral
February 2024, Chemistry & biodiversity,
Mohmmad Younus Wani, and Aijaz Ahmad, and Rayees Ahmad Shiekh, and Khalaf J Al-Ghamdi, and Abilio J F N Sobral
July 2023, Bioorganic chemistry,
Mohmmad Younus Wani, and Aijaz Ahmad, and Rayees Ahmad Shiekh, and Khalaf J Al-Ghamdi, and Abilio J F N Sobral
November 2021, ACS omega,
Mohmmad Younus Wani, and Aijaz Ahmad, and Rayees Ahmad Shiekh, and Khalaf J Al-Ghamdi, and Abilio J F N Sobral
September 2015, Molecules (Basel, Switzerland),
Mohmmad Younus Wani, and Aijaz Ahmad, and Rayees Ahmad Shiekh, and Khalaf J Al-Ghamdi, and Abilio J F N Sobral
January 2022, Medicinal chemistry (Shariqah (United Arab Emirates)),
Mohmmad Younus Wani, and Aijaz Ahmad, and Rayees Ahmad Shiekh, and Khalaf J Al-Ghamdi, and Abilio J F N Sobral
May 2024, ACS infectious diseases,
Mohmmad Younus Wani, and Aijaz Ahmad, and Rayees Ahmad Shiekh, and Khalaf J Al-Ghamdi, and Abilio J F N Sobral
February 2012, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!